<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of anti-Igs in combination with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> promotor <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> on DNA and Ig synthesis in a human follicular germinal centre cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> carrying sIgM and sIgD was investigated </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells responded to both anti-mu and anti-delta chains and to anti-lambda light chains by DNA synthesis, as measured by <z:chebi fb="36" ids="29309">methyl</z:chebi>-(3H)-<z:chebi fb="0" ids="17748">thymidine</z:chebi> incorporation </plain></SENT>
<SENT sid="2" pm="."><plain>Flow cytofluorometric measurements, however, showed that only anti-mu chains induced marked increase in cytoplasmic Ig content </plain></SENT>
<SENT sid="3" pm="."><plain>This result suggests that in certain B-cell subsets the signals elicited via sIgM and sIgD are different </plain></SENT>
</text></document>